| 1 |
33618245 | Aspirin and celecoxib may help to rectify a neurotransmission imbalance in bipolar disorder. | 2021 Apr |
1 |
| 2 |
33813964 | Non-ulcerogenic pyrazolyl 2-hydroxychalcones and pyrazolylpyrazolines derived from naturally existing furochromone (khellin): semi-synthesis, docking study and anti-inflammatory activity. | 2021 Apr 5 |
1 |
| 3 |
32741915 | Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents. | 2020 |
2 |
| 4 |
30391698 | New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: Synthesis, in-vitro and in-vivo screening and molecular modeling studies. | 2019 Mar |
1 |
| 5 |
30763886 | Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds. | 2019 May |
1 |
| 6 |
29936228 | Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation. | 2018 Aug |
1 |
| 7 |
28126288 | Medicinal attributes of 1,2,3-triazoles: Current developments. | 2017 Apr |
1 |
| 8 |
26456703 | Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation. | 2016 Feb |
2 |
| 9 |
26610257 | Toward the understanding of the molecular basis for the inhibition of COX-1 and COX-2 by phenolic compounds present in Uruguayan propolis and grape pomace. | 2016 Dec |
1 |
| 10 |
27530656 | Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. | 2016 Dec |
1 |
| 11 |
25898179 | Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries. | 2015 Jun 1 |
1 |
| 12 |
26839798 | Design, Synthesis, and Biological Evaluation of New 2-Phenyl-4H-chromen-4-one Derivatives as Selective Cyclooxygenase-2 Inhibitors. | 2015 Jan-Mar |
1 |
| 13 |
24794773 | Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents. | 2014 Jun 10 |
1 |
| 14 |
23603366 | Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: reversal by celecoxib. | 2013 Apr |
1 |
| 15 |
20817448 | Measurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry. | 2011 Jan 5 |
1 |
| 16 |
21084865 | Induction of a fast inactivation gating on delayed rectifier Shab K(+) channels by the anti-inflammatory drug celecoxib. | 2011 Jan-Feb |
1 |
| 17 |
21778329 | Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. | 2011 Nov |
1 |
| 18 |
19028575 | Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations. | 2009 Jan 31 |
5 |
| 19 |
18468391 | Applying blood-brain barrier in vitro models to study the influence of drugs on endothelial cells--effects of selected COX-inhibitors. | 2008 Apr |
1 |
| 20 |
18674517 | Characterization of eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo. | 2008 Sep 15 |
1 |
| 21 |
16519515 | Molecular dynamics simulations of arachidonic acid-derived pentadienyl radical intermediate complexes with COX-1 and COX-2: insights into oxygenation regio- and stereoselectivity. | 2006 Mar 14 |
1 |
| 22 |
16952493 | Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. | 2006 Sep |
1 |
| 23 |
16297351 | Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1. | 2005 Dec |
2 |
| 24 |
16689132 | [Nonsteroidal antirheumatics and the kidney]. | 2005 |
1 |
| 25 |
15615524 | Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors. | 2004 Dec 30 |
1 |
| 26 |
12629931 | Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer. | 2003 Jan-Feb |
1 |
| 27 |
12795055 | Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. | 2003 |
1 |
| 28 |
12960371 | Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. | 2003 Sep 16 |
1 |
| 29 |
14552704 | Clinical pharmacology of selective COX-2 inhibitors. | 2003 May-Aug |
1 |
| 30 |
11160644 | Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. | 2001 Feb |
1 |
| 31 |
11412976 | Rationale for the observed COX-2/COX-1 selectivity of celecoxib from Monte Carlo simulations. | 2001 Jun 18 |
2 |
| 32 |
11601668 | Clinical implications of drug interactions with coxibs. | 2001 Oct |
1 |
| 33 |
11889908 | [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives]. | 2001 |
1 |
| 34 |
10804043 | Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. | 2000 Apr |
1 |
| 35 |
10868317 | Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects. | 2000 Jun |
1 |
| 36 |
11055820 | COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs. | 2000 |
1 |
| 37 |
11078056 | Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. | 2000 Oct |
2 |
| 38 |
11317163 | COX-1 sparing and COX-2 inhibitory drugs: the renal and hepatic safety and tolerability profiles of celecoxib. | 2000 May |
1 |
| 39 |
11317164 | The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib. | 2000 May |
1 |
| 40 |
11317165 | Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. | 2000 May |
1 |
| 41 |
10193997 | Role of cyclooxygenase-1 and -2 in health and disease. | 1999 Mar |
1 |
| 42 |
10215599 | Kinetic basis for selective inhibition of cyclo-oxygenases. | 1999 May 1 |
1 |
| 43 |
10330781 | COX 2-selective NSAIDs: biology, promises, and concerns. | 1999 May |
2 |
| 44 |
10509845 | Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. | 1999 Sep |
2 |
| 45 |
10580457 | Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. | 1999 Nov 24 |
1 |
| 46 |
10609815 | Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. | 1999 Dec 18-25 |
1 |
| 47 |
16127636 | COX-2 inhibitors--IBC conference. 12-13 April 1999, Coronado, CA, USA. | 1999 Jul |
1 |
| 48 |
9751091 | Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. | 1998 Sep |
1 |